ScholarWorks@Hanyang University: Koh, Seong-Ho

Detailed Information

Koh, Seong-Ho (고성호)

서울 의과대학 (DEPARTMENT OF NEUROLOGY)

Research Area: 신경과학, 뇌졸중 및 치매

Tel 031-560-2267
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Neural stem cells:12||s disease:11||Alzheimer&apos:11||Phosphatidylinositol 3kinase:11||Ischemic stroke:9||Stroke:9||stroke:8||Neuroprotection:7||Alzheimer's disease:7||neuroprotection:6||LDOPA:6||Amyotrophic lateral sclerosis:6||GV1001:5||neuronal cell death:5||glycogen synthase kinase3:5||neurotoxicity:5||amyloid beta:5||Peptide:4||Amyotrophic Lateral Sclerosis (ALS):4||prognosis:4||Alzheimer’s disease:4||oxidative stress:4||Hypoxia:4||Mesenchymal stem cells:3||Neurotoxicity:3||Upbeat nystagmus:3||Korean:3||regeneration:3||Depression:3||calcium channel blocker:3||inflammation:3||ALS:3||Oxygenglucose deprivation:3||Neuroinflammation:3||Amyloid beta:3||APOE:3||telomere length:3||neural stem cells:3||aging:3||Neurophysiological Index (NI):2||phosphatidylinositol 3kinase:2||phosphatidylinositol3 kinase:2||Clopidogrel bisulfate:2||COVID19:2||Amyotrophic Lateral Sclerosis functional rating scalerevised (ALSFRSR):2||Median nerve:2||Hemiaguesia:2||s dementia:2||s encephalopathy:2||Coenzyme Q10:2||Statin:2||Hemorrhagic transformation:2||Optic neuritis:2||Erythropoietin:2||Mesenchymal stromal cells:2||Escitalopram:2||Survival:2||Microglia:2||PI3K:2||transgenic mouse:2||traumatic brain injury:2||Taste disorder:2||Extracellular signalrelated kinase:2||Telomere:2||donepezil:2||erythropoietin:2||Paragonimus westermani:2||ALS Functional Rating ScaleRevised (ALSFRSR):2||Basilar artery:2||Crohn&apos:2||Alzheimer Disease:2||Deafness:2||Phage display:2||NLRP3 inflammasome:2||Diabetes:2||Unilateral pontine infarction:2||Biomarkers:2||Antioxidant:2||inhibitor:2||Vaccine:2||Validity:2||ischemic stroke:2||lacunar infarction:2||Dickkopf3:2||Neural Stem Cells:2||matrix metalloproteinase9:2||Wernicke&apos:2||Posterior tibial nerve:2||Prognosis:2||mild cognitive impairment:2||multiple sclerosis:2||Korean version:2||Cerebral paragonimiasis:2||Glioblastoma multiforme:2||Neurogenesis:2||amyloid positron emission tomography:2||amyloidbeta:2||Recurrent hemorrhagic stroke:2||Reliability:2||3xTgAD mice:2||ptau181:2||Dysgeusia:2||SOD1:2||Cilostazol:2||MELAS:2||Gutbrain axis:1||H2O2:1||HIF1 alpha:1||HRMRI:1||Hemodynamics:1||Hexanucleotide repeat:1||Highresolution MRI:1||Homology modeling:1||Hounsfield unit:1||Hypoxiainducible factor1 alpha:1||Hypoxia/reoxygenation preconditioning:1||In vivo study:1||Inflammasomes:1||Injections, intraventricular:1||Internal carotid artery stenosis:1||Intracranial hemorrhage:1||Intracranial stenosis:1||Investigatorinitiated trial:1||Ischemia:1||Ischemic stroke model:1||Ischemic vessels:1||Korean Red Ginseng:1||Korean family:1||Korean red ginseng extract:1||LGR5:1||LMNA gene:1||Leu162Pro:1||Leucinerich G proteincoupled receptor5:1||Lower grade glioma:1||MIF:1||MMP9:1||MRI:1||Magnetic:1||Magnetic resonance angiography:1||Magnetic resonance imaging:1||Median terminal latency ratio:1||Meningioma:1||Mesenchymal Stem Cells:1||Mesenchymal stromal cell:1||Metabolic syndrome:1||Microscopic polyangiitis:1||Middle cerebral artery occlusion:1||Migration:1||Mild cognitive impairment:1||MiniMental State Examination:1||Models:1||Morning surge:1||Mutagenesis:1||Mutation:1||Myasthenia gravis:1||NLRP1 inflammasome:1||Naloxone:1||Nanovectors:1||Nasal septum:1||National Health Insurance Service:1||Nausea and vomiting:1||Neonate:1||Neural Stem Cell:1||Neural stem cell differentiation:1||Neuroblastoma:1||Neurodegenerative Diseases:1||Neurodegenerative Disorders:1||Neurodegenerative diseases:1||Neurofilament light chain:1||Neuromyelitis optica spectrum disorder:1||Neuron:1||Neuronal protection:1||Neurons:1||Neuroprotective antioxidant:1||Neuropsychology:1||Neurotrophic effect:1||Neurotrophic factor:1||Neurotrophic factors:1||Nocturnal dipping:1||Novel mutation:1||Nucleus intercalatus:1||Nystagmus:1||Oligomer:1||Oxidative stress:1||Oxygen glucose deprivation:1||PARP:1||PARP1 inhibitor:1||PC12 cells:1||PI3K pathway:1||PKC:1||PP2A:1||Parkinson Disease:1||Parkinson&apos:1||Parkinson’s Disease:1||Pathologic neovascularization:1||Pathophysiology:1||Peptide aptamer:1||Perihypoglossal nuclei:1||Peroneal neuropathy:1||Pituitary adenoma:1||Plaque:1||Plaque geometry:1||Plaque, atherosclerotic:1||Plasma pTau181:1||Poly(ADPribose) polymerase:1||Poly(ADPribose)polymerase:1||Poly(ADPribose)polymerase PARP1:1||Polyneuropathies:1||Probe screening:1||Prognostic factors:1||Progressive multifocal leukoencephalopathy:1||Proliferation:1||Proteomics:1||Ptosis:1||RNF213 protein:1||Randomized controlled trial:1||Research:1||Rupture:1||SDF1 alpha:1||Safety:1||Sex:1||Shortening:1||Shotgun metagenomics:1||Silent brain infarcts:1||Skull:1||Sleep duration:1||Sleep quality:1||Solvent shifting:1||Sparganosis:1||Spinal cord:1||Spinocerebellar ataxia type 6:1||Spirometra mansoni:1||Sporadic:1||Stem Cells:1||Stem cell:1||Stem cell therapy:1||Stem cell transplantation:1||Stroke mechanism:1||Stroke outcome:1||Stromal cellderived factor1 alpha:1||Susceptibilityweighted imaging:1||Symptoms:1||Systemic sclerosis:1||Tau:1||Telmisartan:1||ThDP binding:1||ThDP dependent enzyme:1||The Cancer Genome Atlas:1||Thiopyranoquinoline derivatives:1||Thrombolysis:1||Thymectomy:1||Tissue Therapy:1||TolosaHunt syndrome:1||Tracking:1||Transcarpal motor conduction study:1||Transient upbeat nystagmus:1||Translational Medical Research:1||Treatment:1||Tricyclic derivatives:1||Upper motor neuron signs:1||Uric acid:1||VEGF:1||Ventral tegmental tracts:1||Vertebral artery:1||Viability:1||Wakeup stroke:1||Wnt:1||Wnt signaling pathway:1||Wnt/betacatenin signaling:1||Young adults:1||adult stem cells:1||adultonset vanishing white matter disease:1||amlodipine besylate:1||amlodipine camsylate:1||amyloid:1||amyloid pathology:1||amyloidbeta 42:1||amyotrophic lateral sclerosis:1||angiogenesis:1||animal:1||animal study:1||antiNmethylDaspartate receptor encephalitis:1||antiaging:1||apolipoprotein E:1||apoptosis:1||aqueous humour:1||aspirin:1||astrocyte:1||autosomal dominant:1||betaAmyloid:1||betaPIX:1||betacatenin signaling:1||bloodbrain barrier (BBB):1||bone marrow mesenchymal stromal cells:1||bone mineral density:1||cAMP:1||candesartan:1||carbon monoxide:1||cardioembolic stroke:1||caregiver:1||case report:1||cell protection:1||cell therapy:1||central nervous system:1||cerebral infarction:1||cilnidipine:1||cognition:1||cognitive complaint:1||cognitive stage:1||dementia:1||depressive symptom:1||diabetic macular oedema:1||diabetic retinopathy:1||eligibility:1||exercise:1||familial ALS:1||free radical:1||gait disturbance:1||gaseous molecule:1||gene:1||glial fibrillary acidic protein:1||glioblastoma multiforme:1||glycogen synthase kinase3 (GSK3):1||glycogen synthase kinase3 beta:1||hTERT:1||heme oxygenase1:1||hemorrhagic transformation:1||hetastarch:1||hnRNP:1||hydrogen peroxide:1||hypoxia:1||infarction:1||interleukin6:1||ischemia:1||l3:1||lecanemab:1||mTOR:1||macrophage migration inhibitory factor:1||methotrexate:1||microRNA:1||microRNA polymerase chain reaction array:1||microbleed:1||mutation:1||nAChRs:1||nephrotic syndrome:1||neural stem cells.:1||neurodegeneration:1||neurofilament light:1||neurogenerative disease:1||neurogenesis:1||neurology:1||nicotinic acetylcholine receptors:1||oncogenic signaling pathways:1||osteoporosis:1||outcome:1||ovarian teratoma:1||ptau:1||ptau217:1||parenchymal type hematoma:1||patient outcome assessment:1||peptidebased assay:1||phage display:1||phosphatidylinositol3kinase:1||phosphatidylinositol3kinases:1||phosphoinositide 3 kinase:1||phosphorylated tau181:1||phosphorylated tau217:1||positron emission tomography:1||progression:1||proteomics:1||quality of life:1||s Disease:1||sTREM2:1||secondary amyloidosis:1||silent infarction:1||sleep duration:1||sleep quality:1||stem cell:1||stem cell therapy.:1||subcortical silent brain infarct:1||sublethal dose:1||superoxide dismutase 1 (SOD 1):1||survival:1||systemic lupus erythematosus:1||telomere:1||thrombolytic therapy:1||treatment:1||umbilical cord:1||vascular endothelial growth factor:1||vascular endothelial growth factor (VEGF):1||visfatin:1||young adults:1||1,25dyhydroxyvitamin D3:1||zinc:1||4dihydroxyphenylalanine (LDOPA):1||A beta 42:1||A4F:1||ABCA1:1||AKT:1||Abscess:1||Acetohydroxyacid synthase:1||AcetylLcarnitine:1||Acquired immune deficiency syndrome:1||Acute cerebral infarction:1||Acute motor axonal neuropathy:1||Acute stroke:1||Akt:1||Alzheimer's disease pathology:1||Alzheimer’s Disease:1||Ambulatory blood pressure monitoring:1||Amlodipine besylate:1||Amyloid:1||Amyloid PET:1||Amyloid pathology:1||Amyloid positron emission tomography:1||Amyloidbeta:1||Anger:1||Angiogenesis:1||Animal models:1||AntiGD1b antibody:1||Antiproliferation:1||Antiphospholipid antibody:1||Antiphospholipid syndrome:1||Aqueous humor:1||Aspirin:1||Astrocytes:1||Astrocytic mitochondria biogenesis:1||Asymptomatic states:1||Atherosclerosis:1||Atorvastatin:1||Basilar plaque:1||Benidipine hydrochloride:1||Biological marker:1||Bone density:1||Brain glioma:1||Brain injury:1||Brain stem infarctions:1||C9orf72:1||CXCR4:1||Calcification:1||Calcineurin inhibitor:1||Calcium channel blocker:1||Cancer stem cell:1||Carotid arteries:1||Carpal tunnel syndrome:1||Cavernous malformation:1||Cell death:1||Centiloid:1||Cerebellar Ataxia:1||Cerebral Infarction:1||Cerebral infarction:1||Cervical thymoma:1||Clinical trial:1||Clopidogrel napadisilate:1||Clopidogrel resinate:1||Cluster headache:1||Codon4:1||Cognitive stage:1||Correspondence:1||Cortical thickness:1||Cyclosporine:1||D4Z4 repeat:1||Dementia:1||Diabetic retinopathy:1||Diagnosis:1||Diffusionweighted MRI:1||Disease progression:1||Dissection:1||Downbeat nystagmus:1||EGCG:1||ERK:1||Early diagnosis:1||Early onset dementia:1||Efficacy:1||Embolic stroke:1||EmeryDreifuss muscular dystrophy:1||Emotional incontinence:1||Extracellular signalregulated kinase:1||F20C:1||FUS:1||Facioscapulohumeral muscular dystrophy:1||Familial:1||Familial ALS:1||Frontotemporal Dementia:1||Frontotemporal dementia:1||Functional outcome:1||GSK3:1||GSK3 beta inhibition:1||GSK3 inhibitor:1||GV1001 peptide:1||Gene:1||Gene delivery:1||Genetic Research:1||Gonadotropinreleasing hormone receptors:1||Growth factor:1||Guideline:1||Guillainbarre syndrome:1||Gut microbiome:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE